在cN0口腔状细胞癌的部剖析:免疫治疗的机会
1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of Stomatology, Wuhan University, Wuhan, China; Department of Oral and Maxillofacial-Head Neck Oncology, School and Hospital of Stomatology, Wuhan University, Wuhan, China.
概括
新辅助免疫疗法和观察和等待策略可能为早期口腔状细胞癌 (OSCC) 提供选择性部剖析的替代方案,可能改善结果和生活质量.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 头部和部手术 头部和部手术
背景情况:
- 选择性部剖析是早期口腔状细胞癌 (OSCC) 的标准,但有可能导致并发症和过度治疗.
- 健康的淋巴结对于免疫反应至关重要;它们的缺失可能会损害治疗的有效性.
- 新辅助免疫疗法在早期的OSCC中与更健康的淋巴结需要进行调查.
研究的目的:
- 探索新辅助免疫疗法组合和观察和等待作为早期OSCC部管理的替代方案.
- 为了平衡最佳的存活率与早期OSCC患者的改善生活质量.
- 要总结当前的部管理,淋巴结免疫功能和新辅助免疫治疗证据.
主要方法:
- 对早期OSCC部管理的当前文献的综述.
- 对淋巴结的免疫功能与治疗相关的分析.
- 突出新辅助免疫疗法组合的证据和潜在益处.
主要成果:
- 新辅助免疫疗法组合显示出早期OSCC治疗的潜力.
- 需要进一步的研究来证实新辅助免疫疗法在控制隐性转移中的生存益处.
- 开发非侵入性诊断和风险评估工具可以提高免疫治疗的有效性.
结论:
- 新辅助免疫疗法组合和观察和等待策略是早期OSCC选择性部剖析的有希望的替代方案.
- 优化新辅助免疫疗法需要进一步评估对隐性转移的疗效.
- 诊断和药物输送系统的进步是提高早期OSCC新辅助免疫疗法的关键.
相关概念视频
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:27Cytotoxic T Cells-mediated Immune Response
823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823